Quick Answer
CUMBERLAND PHARMACEUTICALS INC reported Total Assets of $76.82 million for fiscal year 2025.
CUMBERLAND PHARMACEUTICALS INC Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $76.82M | +1.6% |
| 2024 | $75.58M | -7.6% |
| 2023 | $81.78M | -12.0% |
| 2022 | $92.93M | +10.0% |
| 2021 | $84.46M | -12.4% |
| 2020 | $96.46M | -7.7% |
| 2019 | $104.55M | -7.2% |
| 2018 | $112.69M | +20.9% |
| 2017 | $93.23M | -0.2% |
| 2016 | $93.40M | +1.6% |
| 2015 | $91.92M | -3.7% |
| 2014 | $95.41M | +8.9% |
| 2013 | $87.61M | -11.1% |
| 2012 | $98.59M | +3.2% |
| 2011 | $95.52M | +3.8% |
| 2010 | $92.05M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $65.90M | -14.1% | -3.0% |
| June 30, 2025 | $67.91M | -13.5% | -2.9% |
| March 31, 2025 | $69.94M | -14.2% | -7.5% |
| December 31, 2024 | $75.58M | -7.6% | -1.5% |
| September 30, 2024 | $76.75M | -12.5% | -2.3% |
| June 30, 2024 | $78.52M | -12.1% | -3.7% |
| March 31, 2024 | $81.51M | -8.9% | -0.3% |
| December 31, 2023 | $81.78M | -12.0% | -6.8% |
- CUMBERLAND PHARMACEUTICALS INC showed an increase of +1.6% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, CUMBERLAND PHARMACEUTICALS INC’s total assets has declined by 16.5% (from $92.05 million to $76.82 million).
- The most recent figure is from CUMBERLAND PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: